erythrosine and cytarabine

erythrosine has been researched along with cytarabine in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's6 (50.00)18.2507
2000's3 (25.00)29.6817
2010's1 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khoobehi, B; Magin, RL; McTurnan, WG; Niesman, MR; Peyman, GA1
Chi, JC; Holtzer, H; Rubinstein, NA1
Erlichman, C; Hedley, DW; Jamieson, GP; Pressacco, J; Wiley, JS1
Fridborg, H; Killander, A; Kristensen, J; Larsson, R; Liliemark, J; Nygren, P; Oberg, G; Simonsson, B1
Brocklebank, AM; Buolamwini, JK; Jamieson, GP; Paterson, AR; Sawyer, WH; Snook, MB; Wiley, JS1
Belch, AR; Gati, WP; Larratt, LM; Paterson, AR; Turner, AR1
Belch, AR; Chlumecky, V; Gati, WP; Larratt, LM; Mant, MJ; Paterson, AR; Turner, AR1
Bartkowiak, D; Baust, H; Högner, S; Nothdurft, W; Röttinger, EM1
Campone, M; Le Cabellec, MT; Meflah, K; Oliver, L; Vallette, FM; Vavasseur, F1
Albertioni, F; Eriksson, S; Löfgren, C; Månsson, E; Paul, A; Paul, C; Ullberg, K1
Anagnostopoulos, N; Androutsos, G; Galanopoulos, A; Kalmantis, T; Meletis, J; Paterakis, G; Rombos, Y; Sagriotis, A; Symeonidis, A; Tiniakou, M; Tsimberidou, AM; Yataganas, X; Zoumbos, N1
Asano, S; Chen, MH; Izawa, K; Kobayashi, S; Maruyama, K; Soda, Y; Tani, K; Tojo, A1

Reviews

1 review(s) available for erythrosine and cytarabine

ArticleYear
Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).
    Leukemia & lymphoma, 1998, Volume: 32, Issue:1-2

    Topics: Acute Disease; Antimetabolites, Antineoplastic; Carrier Proteins; Cytarabine; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Gene Expression; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Membrane Proteins; Microscopy, Confocal; Nucleoside Transport Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purine Nucleosides

1998

Other Studies

11 other study(ies) available for erythrosine and cytarabine

ArticleYear
Externally triggered release of dye and drugs from liposomes into the eye. An in vitro and in vivo study.
    Ophthalmology, 1988, Volume: 95, Issue:7

    Topics: Animals; Anterior Chamber; Cytarabine; Eye; Fluoresceins; In Vitro Techniques; Liposomes; Rabbits

1988
Actin and myosin in a variety of myogenic and non-myogenic cells.
    Biochemical and biophysical research communications, 1974, Mar-25, Volume: 57, Issue:2

    Topics: Actins; Adenosine Triphosphatases; Animals; Bromodeoxyuridine; Calcium; Carbon Radioisotopes; Cells, Cultured; Chick Embryo; Cytarabine; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Fluoresceins; Leucine; Magnesium; Molecular Weight; Muscles; Myosins; Potassium; Time Factors; Tritium; Trypsin

1974
Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.
    British journal of cancer, 1995, Volume: 72, Issue:4

    Topics: Antimetabolites; Carrier Proteins; Cytarabine; DNA; Fluoresceins; Fluorouracil; Humans; Membrane Proteins; Nucleoside Transport Proteins; Purine Nucleosides; Thymine Nucleotides; Tumor Cells, Cultured

1995
Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
    Leukemia, 1994, Volume: 8, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Agents; Cladribine; Cytarabine; Daunorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Fluoresceins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Tumor Cells, Cultured

1994
Flow cytometric quantitation of nucleoside transporter sites on human leukemic cells.
    Cytometry, 1993, Volume: 14, Issue:1

    Topics: Adenosine; Binding Sites; Carrier Proteins; Cell Line; Cytarabine; Fluoresceins; Humans; Leukemia, Myeloid; Ligands; Membrane Proteins; Nucleoside Transport Proteins; Purine Nucleosides; Thioinosine; Thionucleosides

1993
Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein.
    Blood, 1997, Jul-01, Volume: 90, Issue:1

    Topics: Acute Disease; Adenosine; Affinity Labels; Antimetabolites, Antineoplastic; Carrier Proteins; Cell Death; Cytarabine; Flow Cytometry; Fluorescein; Fluoresceins; Humans; Leukemia; Nucleosides; Thionucleosides; Tumor Cells, Cultured

1997
Comparative analysis of apoptosis in HL60 detected by annexin-V and fluorescein-diacetate.
    Cytometry, 1999, Nov-01, Volume: 37, Issue:3

    Topics: Annexin A5; Apoptosis; Cell Separation; Cytarabine; Flow Cytometry; Fluoresceins; HL-60 Cells; Hot Temperature; Humans; Propidium; Scattering, Radiation; Topotecan

1999
Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein.
    Leukemia, 2001, Volume: 15, Issue:9

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; bcl-X Protein; Caspase 3; Caspases; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Enzyme Activation; Flow Cytometry; Fluoresceins; HL-60 Cells; Humans; Peptide Hydrolases; Phenotype; Probenecid; Protein Biosynthesis; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; X-Linked Inhibitor of Apoptosis Protein

2001
Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy.
    British journal of haematology, 2001, Volume: 114, Issue:3

    Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cyclosporins; Cytarabine; Deoxycytidine Kinase; DNA Fragmentation; Doxorubicin; Drug Resistance, Multiple; Flow Cytometry; Fluoresceins; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute

2001
Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Leukemia research, 2002, Volume: 26, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; Calcium Channel Blockers; Carbocyanines; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Fluoresceins; Fluorescent Dyes; Genistein; Humans; Idarubicin; Immunophenotyping; Leukemia, Myeloid; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Probenecid; Prognosis; Prospective Studies; Rhodamine 123; Survival Analysis; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles; Verapamil

2002
A versatile drug delivery system using streptavidin-tagged pegylated liposomes and biotinylated biomaterials.
    International journal of pharmaceutics, 2013, Sep-15, Volume: 454, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antigens, CD7; Biological Transport; Biotinylation; Cell Survival; Chemistry, Pharmaceutical; Cytarabine; Dose-Response Relationship, Drug; Female; Fluoresceins; Fluorescent Dyes; Granulocyte Colony-Stimulating Factor; Humans; Inhibitory Concentration 50; Jurkat Cells; K562 Cells; Leukemia; Lipids; Liposomes; Mice; Mice, Inbred NOD; Mice, SCID; Polyethylene Glycols; Receptors, Granulocyte Colony-Stimulating Factor; Sialic Acid Binding Ig-like Lectin 3; Streptavidin; Technology, Pharmaceutical; Xenograft Model Antitumor Assays

2013